XML 35 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows (FY) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net loss $ (27,466) $ (8,141)
Adjustments to reconcile net loss to net cash used in operating activities:    
Equity-based compensation expense 2,005 1,265
Depreciation and amortization 55 63
Amortization/accretion on marketable securities 2,514 307
Changes in operating assets and liabilities:    
Prepaid and other current assets (453) 56
Other assets (150) 466
Accounts payable, accrued liabilities and other liabilities 1,250 (2,839)
Net cash used in operating activities (22,245) (8,823)
Cash flows from investing activities:    
Purchase of marketable securities (179,775) (34,799)
Sales of marketable securities 124,939 27,542
Purchases of property and equipment (60) (20)
Net cash used in investing activities (54,896) (7,277)
Cash flows from financing activities:    
Proceeds from exercise of options 24 0
Tax withholding payments on net share settlement equity awards (248) (148)
Net proceeds from issuance of capital stock 85,500 18,728
Net cash (used in) provided by financing activities 85,276 18,580
Net (decrease) increase in cash and cash equivalents 8,135 2,480
Cash and cash equivalents at beginning of period 16,512 14,032
Cash and cash equivalents at end of period 24,647 16,512
Supplemental Disclosure of Cash Flow Information:    
Interest 0 0
Taxes $ 0 $ 0